Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH

    AYUSH - Page 7

    Substandard: Nepal drugs watchdog asks Patanjali to recall six medicines

    Substandard: Nepal drugs watchdog asks Patanjali to recall six medicines

    Ruby Khatun Khatun25 Jun 2017 9:20 AM IST
    Kathmandu: Nepal's drugs watchdog has asked Ramdev's Patanjali Ayurveda to recall six Ayurvedic medicines after they were found to be of "substandard...
    Dr Batra’s Offers Free Preventive Dosage for Swine Flu Across the Country

    Dr Batra’s Offers Free Preventive Dosage for Swine Flu Across the Country

    Ruby Khatun Khatun21 Jun 2017 11:07 AM IST
    Mumbai: The recent outbreak of swine flu has gripped the nation with fear and panic. According to media reports, the hotspots this year are western...
    Baba Ramdev to launch 10,000 Patanjali Wellness Centres globally

    Baba Ramdev to launch 10,000 Patanjali Wellness Centres globally

    Ruby Khatun Khatun19 Jun 2017 12:41 PM IST
    Ahmedabad: Yoga guru Baba Ramdev said he has plans to launch 10,000 Patanjali Wellness and Health Centres globally to popularise yoga.The Gujarat...
    Patanjali eyes Rs 1 lakh-crore turnover in next 5 years

    Patanjali eyes Rs 1 lakh-crore turnover in next 5 years

    Ruby Khatun Khatun14 May 2017 10:59 AM IST
    Ahmedabad: Baba Ramdev-led home-grown FMCG major Patanjali Ayurved, which posted a turnover of Rs 10,561 crore in the last fiscal, is now looking at a...
    Patanjali to wipe out MNCs from Indian market in 5 years: Ramdev

    Patanjali to wipe out MNCs from Indian market in 5 years: Ramdev

    Ruby Khatun Khatun2 May 2017 11:12 AM IST
    Saharanpur: Yoga guru Ramdev said on Sunday that Patanjali Ayurveda, promoted by him, will steal the march over multinational firms manufacturing...
    Drugs being developed under the AYUSH system of medicine, Check out details

    Drugs being developed under the AYUSH system of medicine, Check out details

    supriya kashyap kashyap3 April 2017 11:32 AM IST
    Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central...
    Pact to check misleading ads of Ayurvedic medicines

    Pact to check misleading ads of Ayurvedic medicines

    supriya kashyap kashyap26 March 2017 10:11 AM IST
    New Delhi : The government has signed a pact with the Advertising Standards Council of India to check misleading advertisements of Ayurvedic...
    Ayush medicines to be sold at generic medicine stores: Shripad Naik

    Ayush medicines to be sold at generic medicine stores: Shripad Naik

    supriya kashyap kashyap18 March 2017 2:02 PM IST
    New Delhi : Ayush medicines could soon be sold at the generic medicine stores run by the Health Ministry.Ayush Minister Shripad Naik informed the Lok...
    AYUSH ministry invites global drug makers to set up plants in India

    AYUSH ministry invites global drug makers to set up plants in India

    supriya kashyap kashyap25 Feb 2017 10:36 AM IST
    New Delhi : AYUSH Minister Shripad Yesso Naik invited drug manufacturers from across the world to set up their plants in the country under the 'Make...
    Several new drugs have been developed under AYUSH System: Shri Shripad Naik

    Several new drugs have been developed under AYUSH System: Shri Shripad Naik

    supriya kashyap kashyap8 Feb 2017 10:39 AM IST
    Central Council for Research in Ayurvedic Sciences (CCRAS) has developed anti-diabetic drug AYUSH-82 and AYUSH-SG for Rheumetoid Arthritis. Central...
    FDA confirms elevated levels of belladonna in certain homeopathic teething products

    FDA confirms elevated levels of belladonna in certain homeopathic teething products

    supriya kashyap kashyap28 Jan 2017 12:26 PM IST
    The U.S. Food and Drug Administration announced that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain...
    ICRA upgrades long term rating on Patanjali Ayurved

    ICRA upgrades long term rating on Patanjali Ayurved

    supriya kashyap kashyap21 Jan 2017 12:30 PM IST
    New Delhi : Credit rating agency ICRA has upgraded long term rating on Baba Ramdev-led Patanjali Ayurved Ltd (PAL) to enhanced degree of adequate...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok